TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium
University of Colorado, Denver
5,000 participants
Jan 1, 2015
OBSERVATIONAL
Conditions
Summary
A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).
Eligibility
Inclusion Criteria1
- Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer
Exclusion Criteria1
- Patients with squamous cell carcinoma
Interventions
Endoscopic eradication therapies (EET) includes endoscopic mucosal resection (EMR), which describes the process by which the area most likely to harbor highest grade of dysplasia/neoplasia is removed; radiofrequency ablation (RFA), which describes the process by which Barrett's segments are removed via burning/ablation; and cryotherapy.
The esophagus is surgically removed
Chemical substances are used to treat cancer
Cancer cells are destroyed by radiation therapy.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02634645